Mirati Therapeutics, Inc.·4

Jan 3, 6:01 PM ET

Sandler Alan B. 4

4 · Mirati Therapeutics, Inc. · Filed Jan 3, 2024

Insider Transaction Report

Form 4
Period: 2023-12-29
Sandler Alan B.
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-12-29$58.75/sh+17,021$999,98479,318 total
Footnotes (1)
  • [F1]Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested.

Documents

1 file
  • 4
    wk-form4_1704322844.xmlPrimary

    FORM 4